Get started
Work

Androgen Deprivation Therapy (ADT) and High Dose Definitive Radiotherapy (RT) ± Whole Pelvic RT in Patients with Unfavorable Intermediate or Favorable High-Risk Prostate Cancer: Early Results of a Phase III Randomized Controlled Trial

Year: 2025
Type: article
Study design: Clinical Trial
DOI: 10.1016/j.ijrobp.2025.08.029
Authors: M. Roach, T.G. Karrison, H.T. Chung, A.J. Chang, L.G. Gomella, I.C.J. Hsu, G. Morton, R.E. Wallace, B. Movsas, D.W. Bruner, A.P. Dicker, D.E. Citrin, I. Kauffman, J.M. Michalski, E. Vigneault, M.A. Papagikos, D.E. Spratt, A. Jani, T. Johnson, H.M. Sandler
Institutions: University of California, San Francisco, NRG Oncology, Sunnybrook Health Science Centre, University of Toronto, Odette Cancer Centre, University of California, Los Angeles, Thomas Jefferson University, Sidney Kimmel Cancer Center, Cedars-Sinai Medical Center, Henry Ford Health, Henry Ford Hospital, Emory University, National Institutes of Health, National Cancer Institute, Wayne State University, The Barbara Ann Karmanos Cancer Institute, Washington University in St. Louis, Hôtel-Dieu de Québec, University Hospitals Cleveland Medical Center, University Hospitals Seidman Cancer Center
Language: English
Field: Medicine
Open Access status: closed
OpenAlex ID: W4415170337
FWCI: 5.315
Cites:
Cited by: 9
Related to: